Abstract
Interferon dose increase for early (week 12) non-responders to interferon alfa-2b + ribavirin therapy for chronic hepatitis C does not lead to viral response at 48 weeks: Norbert Bräu, Peiying Xiao, Douglas A Finch, Charles S Lieber, Bronx VA Medical Ctr and Mount Sinai School of Medicine, Bronx, NY
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
